Biocept Inc

5810 Nancy Ridge Dr Ste 150 , San Diego, CA 92121

Public
Healthcare & Pharmaceuticals - Diagnostic Laboratories
around $2.5 - 5M
around 20 - 50
(858) 320-8200
(858) 320-8225


Biocept, Inc. is an early commercial-stage molecular oncology diagnostics company. The Company develops and commercializes circulating tumor cell (CTC) and circulating tumor deoxyribonucleic acid (ctDNA), assays utilizing a standard blood sample, or liquid biopsy. The Company's Target-Selector offering is based on an internally developed, microfluidics-based CTC capture and analysis platform, with enabling features that change how CTC testing can be used by clinicians by providing biomarker detection and monitoring requiring only a standard blood sample. The ctDNA technology enables mutation detection and is applicable to nucleic acid from CTCs or other sample types, such as blood plasma. The Company commercializes its Target-Selector assays for a range of solid tumor indications, such as ... (Source: SEC reports)


Competitor - 1/9
Which company is more competitive with Biocept Inc?


40 Contacts at this company
Beverly Wolgast
Manufacturing Manager
Marc Wojcik
Account Executive
Martin Lo
Manufacturing Project Leader
Robbie Schultz
Translational Scientist
Michael Dunn
SVP, Corporate Development
Vassilios Alexiadis
Principal Scientist
Yehudit Gerassi
Manufacturing manager
Lara Price, MBA
Senior Manager, Accounting
Tony J Pircher
Director of Immunochemistry

Nov 5, 2018 17:23:03
SAN DIEGO, Nov. 5, 2018 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the [...]

Sep 13, 2018 05:22:23
SAN DIEGO, Sept. 10, 2018 /PRNewswire/ -- Biocept, Inc. (NASDAQ : BIOC ), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to [...]

Sep 10, 2018 16:57:32
SAN DIEGO, Sept. 10, 2018 /PRNewswire/ -- Biocept, Inc. (NASDAQ : BIOC ), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to [...]

Sep 5, 2017 21:36:46
SAN DIEGO, Sept. 5, 2017 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve [...]

Aug 17, 2017 21:37:00
SAN DIEGO, Aug. 17, 2017 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to [...]

Get Started Today : Sign up in 20 seconds
Search with 20+ criteria.
Export results in seconds.
Bad emails?
No worry, we give two extras for every bad email.